Onyx Bridge Wealth Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
Onyx Bridge Wealth Group's ABBV Position: Q2 2026 in Review
Onyx Bridge Wealth Group increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $54.9K and bringing the position to 6,409 shares worth $1.61M. The position accounts for 0.15% of the portfolio, ranked #121.
Onyx Bridge Wealth Group first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 1,651 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Onyx Bridge Wealth Group held 6,409 shares of AbbVie worth $1.61M as of Q2 2026.
- Onyx Bridge Wealth Group bought 255 AbbVie shares in Q2 2026, an estimated $54.9K.
- AbbVie made up 0.15% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #121 holding.
- Onyx Bridge Wealth Group first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
- 1,651 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.